Trial Details

Not Recruiting
Basic Information
Clinical ID c5087
Identifier EUCTR2016-003797-40-BE
Trial Title A Phase 2a, Proof of Concept, Open-label Study Evaluating the Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients with active Skin Extra-intestinal Manifestations
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Active Skin Extra-Intestinal Manifestations in Inflammatory Bowel Disease.;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Product Name: APD334Pharmaceutical Form: TabletINN or Proposed INN: Not yet availableCAS Number: 1206123 97 8Current Sponsor code: APD334Other descriptive name: APD334Concentration unit: mg milligram(s)Concentration type: e
Participant Information
Sponsor Arena Pharmaceuticals, Inc.
City NULL
Country/Region United States;Belgium;Germany
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE2
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL